Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 58INDUSTRY 38NIH 5NETWORK 3UNKNOWN 1OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 3Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Nasopharyngeal Neoplasms 1Locally Advanced Malignant Neoplasm 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

apatinib 2Etoposide 2tislelizumab 1camrelizumab 1anlotinib 1Radiotherapy 1Irinotecan 1Immunotherapy 1Drug Therapy 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Small Cell Lung Carcinoma × Cisplatin × Clear all
NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡